| Notice Filed with SOS |
08/31/2021 |
| Rule |
ProposedRuleAttach2021-00552.doc |
| Statutory Authority |
Sections 12-20-204(1), 12-280-101, 12-280-107, 12-280-108(3)(b), 12-280-115.5(3)(b)(II), and 24-4-103, C.R.S. |
| Description of Subjects/Issues |
The purpose of this Permanent Rulemaking Hearing is for the Board to consider adopting new and revised rules to provide clarity and a general cleanup of the rules; and implement Colorado Senate Bill 21-011 (Concerning responsibilities of a pharmacist related to opiate antagonists); Colorado Senate Bill 21-077 (Concerning the elimination of verification of an individual's lawful presence in the United States as a requirement for individual credentialing); Colorado Senate Bill 21-094 (Concerning the continuation of the State Board of Pharmacy, and implementing recommendations contained in the 2020 sunset report by the Department of Regulatory Agencies and making other changes regarding the practice of professions regulated by the Board); Colorado Senate Bill 21-098 (Concerning the continuation of the prescription drug monitoring program); Colorado Senate Bill 21-122 (Concerning the bulk purchase of opiate antagonists pursuant to a standing order); and Colorado Senate Bill 21-123 (Concerning expanding the Canadian prescription drug importation program to include prescription drug suppliers from nations other than Canada upon the enactment of legislation by the United States congress authorizing such practice). |
| Purpose/Objective of Rule |
The purpose the Board adopting new and revised rules was to provide clarity and a general cleanup of the rules; and implement Colorado Senate Bill 21-011 (Concerning responsibilities of a pharmacist related to opiate antagonists); Colorado Senate Bill 21-077 (Concerning the elimination of verification of an individual's lawful presence in the United States as a requirement for individual credentialing); Colorado Senate Bill21-094 (Concerning the continuation of the State Board of Pharmacy, and implementing recommendations contained in the 2020 sunset report by the Department of Regulatory Agencies and making other changes regarding the practice of professions regulated by the Board); Colorado Senate Bill 21-098(Concerning the continuation of the prescription drug monitoring program);Colorado Senate Bill 21-122 (Concerning the bulk purchase of opiate antagonists pursuant to a standing order); and Colorado Senate Bill 21-123 (Concerning expanding the Canadian prescription drug importation program to include prescription drug suppliers from nations other than Canada upon the enactment of legislation by the United States congress authorizing such practice). |
| Submitted in response to issues raised by COLS/OLLS? |
No
|
| Is this rule adopted in response to recent legislation? |
Yes
|
| Recent legislation bill number |
SB21-011, SB21-077, SB21-094, SB21-098, SB21-122, and SB21-123.
|
| Hearing Date |
09/30/2021 |
| Hearing Time |
08:45 AM |
| Hearing Location |
Webinar Only: https://attendee.gotowebinar.com/register/4706927231820273422 |
| Contact Name |
Elena M. Kemp |
| Contact Title |
Regulatory Coordinator |
| Contact Telephone |
303-894-7426 |
| Contact email |
dora_dpo_rulemaking@state.co.us |